COP — ConocoPhillips

Sentiment turned decisively positive on the August 6, 2026 Q2 print: adjusted earnings of ~$4.0B/$3.24 per share beat consensus by roughly $0.35, revenue rose ~32–37% year-over-year to $19.16B, Permian volumes set a company record above 900,000 BOED, and management doubled quarterly buybacks ($2.0B repurchases + $1.0B dividends = $3.0B returned). The stock responded — up 7.89% over the month and 17.41% over three months into 2026-09-13, with an RSI of 67.49 and price 20.8% above its 200-day average. Analyst posture is constructive (Buy consensus; 38 Buy + 1 Strong Buy vs. 10 Hold and 3 Sell; price targets clustered $146–$153 with a $150.82 consensus). The offsetting note in the tape is the leadership handoff: Andy O'Brien took over as CEO on September 1, 2026, with Ryan Lance moving to Executive Chair and Konnie Haynes-Welsh becoming CFO — a real transition, but one the market has so far read as continuity rather than disruption.

The three-year arc is clearly cyclical with a sharp 2026 inflection, not a smooth trend. Revenue ran $14.2–14.7B per quarter through 2023, sagged to $13.0–14.2B through 2024, and bottomed at $13.39B in Q4 2025 before snapping back to $15.76B in Q1 2026 and $19.16B in Q2 2026 (+36.8% YoY vs. Q2 2025's $14.00B). Margins tell the same story: operating margin compressed from ~28% in Q4 2023 to a trough of 13.1% in Q4 2025 (operating income $1.76B), then jumped to 21.5% in Q1 2026 and 31.2% in Q2 2026 — the highest in the dataset. EPS traced $2.31–2.52 in 2023, $1.76–2.15 in 2024, collapsed to $1.16–1.38 in H2 2025, then recovered to $1.78 (Q1 2026) and $3.23 (Q2 2026). Free cash flow is the loudest volatility signal: $2.9B in Q3 2023, $1.14B in Q4 2024, a genuinely alarming -$786M in Q3 2025 when capex spiked to $6.66B against a $5.88B operating cash flow, then $4.41B in Q2 2026 on capex of just $3.02B. Read this straight: the 2026 acceleration is real and delivered, but it is being driven by commodity realizations and a depressed 2025 comparison base, not by a structural re-rating of the business. Q2 2026 at a 31% operating margin is closer to a cycle peak than a new normal, and the Q3 2025 capex blowout shows how quickly FCF can flip negative.

Not cheap. As of 2026-09-13 the trailing P/E was 18.17x against a 5-year average of 12.02x, price/sales was 2.64x against a 5-year average of 2.12x, and price/book was 2.55x — the deterministic overlay flags this as 'Rich vs. its own history' (score 9.6/100). The trailing numbers overstate the expense because the 'E' includes the washed-out H2 2025. On forward earnings the picture normalizes: at the next-FY consensus EPS of $10.369, the forward P/E is 13.25x, and if FY2026 lands near $9.8–10.0 the multiple is ~14x — a modest premium to the 12.0x five-year average, not an extreme one. The PEG of 13.55 is meaningless here (it divides a cyclical trailing growth rate into a cyclical multiple). EV/EBITDA of 6.60x is mid-range for a large-cap E&P and the 2.63% dividend yield plus $2.0B/quarter of buybacks provides a real cash return. Verdict: fair-to-slightly-full on forward earnings, expensive on trailing, with no valuation cushion if oil prices soften. ROIC of 6.4% is the number that most limits how much multiple I'm willing to pay.

This is the reverse of the classic 'priced for growth that hasn't shown up' setup — the market is paying a high trailing multiple on earnings that were temporarily depressed, and the stock has run 17.41% in three months because the earnings actually arrived (a ~$0.35 Q2 beat and a 31.2% operating margin). The forward P/E of ~13.3x says the market is discounting roughly $10+ of EPS, which requires a supportive crude price deck plus the guided 2.29–2.32 MMBOED Q3 production to hold. So the setup is: if oil stays firm, estimates of $10.37 hold or rise and the stock is reasonably priced; if Brent/WTI rolls over, both the E and the P/E compress at once and $137 becomes expensive fast. The honest read is that the easy money from the earnings recovery has been made in the last quarter — what's left requires the commodity to cooperate.

As of 2026-09-13, RSI(14) stood at 67.49 — strong momentum, just shy of the 70 overbought threshold, not yet a sell signal. Price was 3.2% above the 20-day (~$133), 11.9% above the 50-day (~$123), and 20.8% above the 200-day (~$114), an established uptrend with the stock extended well above trend support. Returns of +2.3% (1wk), +7.89% (1mo), +17.41% (3mo), and +12.68% (6mo) confirm accelerating momentum, and at $137.35 the shares sit within ~1% of the 52-week high of $138.89. Implication for timing: this is a hold-onto-it tape, not a great entry tape. Buying 21% above the 200-day with RSI near 70 and the stock at the top of its range offers poor risk/reward; a pullback toward the 50-day around $123 would reset the setup materially. Momentum traders can stay long with a stop, but new capital chasing here is paying up for a chart that is already extended.

• Crude oil price (Brent/WTI) is the single dominant driver — COP sells unhedged production into global markets, so a firm price deck is what underpins the $10.37 forward EPS and the $2.0B/quarter buyback; a sustained slide compresses earnings, free cash flow, and distributions simultaneously.
• Permian/Waha natural gas takeaway constraints are widening differentials versus Henry Hub, pressuring Lower 48 gas realizations even as oil volumes hit records — a structural midstream bottleneck rather than a company-specific problem.
• LNG demand remains structurally strong as natural gas consolidates its role as a transition fuel, which underpins the value of COP's scaling offtake (~12 MTPA) and its Qatar and Port Arthur liquefaction projects.
• Oilfield services inflation versus capital discipline: management has anchored full-year 2026 capex at $12.0–12.5B and a ~45%-of-CFO shareholder return commitment, and any creep above that guidance hits free cash flow directly.
• Sector rotation and a reported beta of just 0.134 means COP trades far more as a commodity/energy-complex instrument than as broad-index beta — it will move on oil fundamentals and energy sector flows rather than rate expectations or general market direction.

• Q3 2026 earnings in early November 2026, with production guided at 2.29–2.32 MMBOED; seasonal turnarounds in Alaska, Norway, and Malaysia are the key swing factor and could cut volumes sequentially even with Q2's record base.
• Execution under new leadership: CEO Andy O'Brien (effective September 1, 2026) and new CFO Konnie Haynes-Welsh — the first capital-allocation and strategy signals from the new team will be closely read.
• Continued doubling of buybacks ($2.0B/quarter) plus the $0.84/share dividend, funded by the 45%-of-CFO return framework, plus further non-core asset sales after the $5B disposition target was hit ahead of schedule.
• LNG expansion milestones — scaling offtake toward 12 MTPA and progress on liquefaction in Qatar and Port Arthur — as the main structural growth lever beyond the Permian.
• Progress toward management's stated $7B free cash flow inflection target by 2029, which is the number that would justify a higher through-cycle multiple.

• Commodity price risk is the whole thesis: forward EPS of $10.37 and the current buyback pace both assume supportive oil prices, and a sustained decline would hit earnings, FCF, and shareholder returns at the same time.
• Valuation risk versus its own history — 18.17x trailing P/E versus a 12.02x five-year average leaves little room for error; the multiple can compress even if earnings merely stop growing, and the stock is already within 1% of its 52-week high.
• Widening Permian/Waha gas differentials versus Henry Hub, which already pressured Lower 48 gas realizations in Q2 2026 and are outside company control.
• Free cash flow volatility: the -$786M FCF quarter in Q3 2025 (capex $6.66B) shows how fast a capex spike can erase a quarter's cash generation, and capex guidance of $12.0–12.5B is not guaranteed to hold against services inflation.
• Low ROIC of 6.4% relative to the cost of capital, combined with capital-heavy multi-year LNG projects, raises the risk that growth capital is deployed at returns that don't create value — the balance sheet strength (D/E 0.356) buys time but doesn't fix returns.

ConocoPhillips is a high-quality, low-leverage E&P that just delivered a genuinely excellent quarter and is doing the right things — record Permian volumes, doubled buybacks, $4.41B of Q2 free cash flow, and real LNG optionality. But as of 2026-09-13 you are paying $137.35 for it: 18.17x trailing earnings versus a 12.02x five-year average, 13.25x forward EPS, RSI 67.49, and a price 20.8% above its 200-day moving average and within 1% of its 52-week high. My blended fair value of ~$138 says the recovery is already in the price. Own it, collect the 2.63% dividend and buyback, and add on weakness toward the 50-day (~$123) — but this is not a spot to chase.

Blended three-method valuation, weighted 40/30/30: 13.5x next-FY consensus EPS of $10.369 (= $140, a premium to the 12.0x five-year average justified by lower leverage and LNG optionality but capped by 6.4% ROIC), 6.75x TTM EBITDA of ~$27.8B less ~$16.3B net debt (= ~$141/share), and a 5.5% required yield on ~$9B of normalized free cash flow (= ~$134/share), averaging to ~$138 — essentially in line with the 2026-09-13 price of $137.35, i.e. the upswing is already discounted.